Is this small cap just too cheap after revenue soars 17%?

Could this niche operator be an outperformer in a cyclical industry?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today’s interim results from building products, systems and solutions group Alumasc (LSE: ALU) show that it performed well in the six months to 31 December. In particular, it posted strong revenue growth of 17%.

Could this small cap, which provides premium products and often bespoke solutions in high-growth niches, be a more resilient performer through construction and housebuilding cycles than general housebuilder and FTSE 100 giant Persimmon (LSE: PSN)?

Lucrative growth

Despite Alumasc’s impressive 17% rise in revenue, up to £50.7m from £43.5m in H1 last year, the increased cost of imported materials following the depreciation of sterling over the last six months impacted on margins. Underlying pre-tax profit increased just 2%, rising to £4.1m from £4.0m.

However, management said selling-price increases and operational gearing, driven by strong growth in revenues, will see stronger margins in H2.

I like Alumasc’s collection of businesses. In particular, Levolux, its solar shading and screening business, is growing fast. It achieved revenue growth of 46% to £11.1m. Notably, this business is experiencing strong demand in North America, which looks set be a lucrative market for the future.

Levolux accounts for the majority of Alumasc’s total order book which currently stands at £27.6m. And with most of these projects due to complete before the financial year-end, the Board said its  expectations for the full-year remain on track.

Attractive valuation

The house broker’s forecast ahead of today’s results was for full-year revenue of £96.6m and earnings per share of 20p. The shares are currently trading at 172p, putting Alumasc on a highly attractive P/E of 8.6. While the company clearly isn’t immune to external forces, it appears to be well-managed and the low P/E provides a good margin of safety against any cyclical downturn in the wider markets to which the group is exposed.

With the company also offering a 4% dividend yield (covered almost three times by earnings) and having net cash on the balance sheet of £5.2m, the shares look very buyable to me at their current level.

Housebuilding

Alumasc’s housebuilding products business is its smallest. It posted revenue of £4.4m (up 8%) during the period and a 22% increase in operating profit at a margin of 15.8%.

The equivalent numbers for Footsie housebuilder Persimmon were even more impressive, demonstrating the benefits of its scale and efficiency. Revenue of £1.5bn was up 12%, while operating profit increased 30% at a margin of 23.8%.

Also attractively valued

Like Alumasc, Persimmon has net cash on its balance sheet (£913m at 31 December). Its P/E is a little higher than Alumasc’s, standing at 9.9 at a share price of 1,925p, but still provides some margin of safety. Furthermore, Persimmon offers a more generous dividend yield of 5.7%.

The company said in a trading update earlier this month that it remains “mindful of the risks associated with the uncertainty arising from the UK’s decision to leave the EU” but that fundamentals continue to be supportive for housebuilding and demand remains healthy.

On the strength of this, as well as the cheap P/E and generous dividend, I also rate blue-chip Persimmon as a ‘buy’.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »

Young black woman using a mobile phone in a transport facility
Market Movers

Meta stock slumps 13% after poor results. Here’s what I’ll do

Jon Smith flags up the reasons behind the fall in the Meta stock price overnight, along with his take on…

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 FTSE stocks I wouldn’t ‘Sell in May’

If the strategy had any merit in the past, I see no compelling evidence it's a smart idea today. Here…

Read more »